As of 2026-11-01, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (44.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.35 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -1427.4%.
The range of the Relative Valuation is (32.16) - (40.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 40.3x | 28.8x |
| Forward P/E multiples | 17.7x - 22.5x | 20.2x |
| Fair Price | (32.16) - (40.84) | (44.47) |
| Upside | -1060.1% - -1319.1% | -1427.4% |
| Date | P/E |
| 2026-10-29 | -1.88 |
| 2026-10-28 | -1.92 |
| 2026-10-27 | -1.91 |
| 2026-10-26 | -1.88 |
| 2026-10-23 | -1.94 |
| 2026-10-22 | -2.11 |
| 2026-10-21 | -2.00 |
| 2026-10-20 | -1.91 |
| 2026-10-19 | -1.90 |
| 2026-10-16 | -1.98 |
| 2026-10-15 | -2.08 |
| 2026-10-14 | -2.11 |
| 2026-10-13 | -1.97 |
| 2026-10-12 | -2.21 |
| 2026-10-09 | -2.26 |
| 2026-10-08 | -2.30 |
| 2026-10-07 | -2.28 |
| 2026-10-06 | -2.32 |
| 2026-10-05 | -2.37 |
| 2026-10-02 | -2.41 |
| 2026-10-01 | -2.49 |
| 2026-09-30 | -2.64 |
| 2026-09-29 | -2.46 |
| 2026-09-28 | -2.53 |
| 2026-09-25 | -2.41 |
| 2026-09-24 | -2.40 |
| 2026-09-23 | -2.55 |
| 2026-09-22 | -2.60 |
| 2026-09-21 | -2.47 |
| 2026-09-18 | -2.45 |
| 2026-09-17 | -2.56 |
| 2026-09-16 | -2.50 |
| 2026-09-15 | -2.52 |
| 2026-09-14 | -2.63 |
| 2026-09-11 | -2.71 |
| 2026-09-10 | -2.73 |
| 2026-09-09 | -2.79 |
| 2026-09-08 | -2.90 |
| 2026-09-04 | -2.92 |
| 2026-09-03 | -2.95 |
| 2026-09-02 | -2.97 |
| 2026-09-01 | -2.89 |
| 2026-08-31 | -3.01 |
| 2026-08-28 | -3.13 |
| 2026-08-27 | -2.79 |
| 2026-08-26 | -2.71 |
| 2026-08-25 | -2.72 |
| 2026-08-24 | -2.68 |
| 2026-08-21 | -2.66 |
| 2026-08-20 | -2.68 |